Source: Journal of Pharmacy and Pharmacology. Unidades: FFCLRP, FCFRP, FMRP
Subjects: ANTINEOPLÁSICOS, CANABINOIDES, CITOCINAS, DOR CRÔNICA, FARMACOTERAPIA, RECEPTORES
ABNT
SANTOS, Rafaela dos et al. Cannabidiol prevents chemotherapy-induced neuropathic pain by modulating spinal TLR4 via endocannabinoid system activation. Journal of Pharmacy and Pharmacology, v. 75, n. 5, p. 655-665, 2023Tradução . . Disponível em: https://doi.org/10.1093/jpp/rgad023. Acesso em: 08 out. 2025.APA
Santos, R. dos, Veras, F. P., Gonçalves Netto, W., Elisei, L., Sorgi, C. A., Faccioli, L. H., & Galdino, G. (2023). Cannabidiol prevents chemotherapy-induced neuropathic pain by modulating spinal TLR4 via endocannabinoid system activation. Journal of Pharmacy and Pharmacology, 75( 5), 655-665. doi:10.1093/jpp/rgad023NLM
Santos R dos, Veras FP, Gonçalves Netto W, Elisei L, Sorgi CA, Faccioli LH, Galdino G. Cannabidiol prevents chemotherapy-induced neuropathic pain by modulating spinal TLR4 via endocannabinoid system activation [Internet]. Journal of Pharmacy and Pharmacology. 2023 ; 75( 5): 655-665.[citado 2025 out. 08 ] Available from: https://doi.org/10.1093/jpp/rgad023Vancouver
Santos R dos, Veras FP, Gonçalves Netto W, Elisei L, Sorgi CA, Faccioli LH, Galdino G. Cannabidiol prevents chemotherapy-induced neuropathic pain by modulating spinal TLR4 via endocannabinoid system activation [Internet]. Journal of Pharmacy and Pharmacology. 2023 ; 75( 5): 655-665.[citado 2025 out. 08 ] Available from: https://doi.org/10.1093/jpp/rgad023